New Hampshire Code of Administrative Rules
Den - State Board of Registration of Funeral Directors and Embalmers
Chapter Den 500 - ETHICAL AND PROFESSIONAL DUTIES
Part Den 503 - OPIOID PRESCRIBING
Section Den 503.05 - Chronic Pain
Current through Register No. 40, October 3, 2024
If opioids are indicated and clinically appropriate for prescription for chronic pain, prescribing licensees shall:
(a) Conduct and document an examination of the oral cavity and associated structures and a medical history;
(b) Conduct and document a risk assessment, including, but not limited to, the use of an evidence-based screening tool such as the Screener and Opioid Assessment for Patients with Pain (SOAPP);
(c) Document the prescription and rationale for all opioids;
(d) Prescribe for the lowest effective dose for a limited duration;
(e) Comply with all federal and state controlled substances laws, rules, and regulations;
(f) Utilize a written informed consent that explains the following risks associated with opioids:
(g) Create and discuss a treatment plan with the patient. This shall include, but not be limited to the goals of treatment, in terms of pain management, restoration of function, safety, time course for treatment, and consideration of non-pharmacological modalities and non-opioid therapy. Informed consent documents and treatment agreements may be part of one document for the sake of convenience;
(h) Utilize a written treatment agreement that is included in the medical record, and specifies conduct that triggers the discontinuation or tapering of opioids;
(i) The agreement shall also address, at a minimum, the following:
(j) Document the consideration of a consultation with an appropriate specialist in the following circumstances:
(k) Reevaluate treatment plans and use of opioids at least twice a year;
(l) Require random and periodic urine drug testing at least annually for all patients using opioids for longer than 90 days. Unanticipated findings shall be addressed in a manner that supports the health of the patient;
(m) Have clinical coverage available for 24 hours per day, 7 days per week, to assist in the management of patients; and
(n) The prescribing licensee may forego the requirements for a written treatment agreement and for periodic drug testing for patients: